Key Insights

Highlights

Success Rate

86% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 42/100

Termination Rate

4.4%

6 terminated out of 135 trials

Success Rate

86.4%

-0.2% vs benchmark

Late-Stage Pipeline

25%

34 trials in Phase 3/4

Results Transparency

16%

6 of 38 completed with results

Key Signals

6 with results86% success

Data Visualizations

Phase Distribution

98Total
Not Applicable (49)
Early P 1 (1)
P 1 (1)
P 2 (13)
P 3 (14)
P 4 (20)

Trial Status

Unknown48
Completed38
Recruiting26
Active Not Recruiting7
Terminated6
Not Yet Recruiting5

Trial Success Rate

86.4%

Benchmark: 86.6%

Based on 38 completed trials

Clinical Trials (135)

Showing 20 of 20 trials
NCT05605288Not ApplicableCompletedPrimary

Distal Versus Conventional Transradial Artery Access for Coronary Catheterization in Patients With STEMI

NCT07646977Not ApplicableNot Yet RecruitingPrimary

CORonary Thrombus Modification to Prevent MIcrovascular Damage in Patients With ST-segment Elevation Myocardial Infarction (The CORMI Trial)

NCT04573751Not ApplicableCompletedPrimary

The EPIVER Randomized Controlled Trial

NCT02789098Not ApplicableTerminatedPrimary

Relationship Between Left Ventricular Remodeling, Coronary Endothelial Function and Myocardial Fibrosis Using Positron Emission Tomography in Patients With ST-elevation Myocardial Infarction

NCT05781087Active Not Recruiting

Predicting the Risk of Non-culprit Coronary Artery Disease After a Heart Attack

NCT06353594Not ApplicableRecruitingPrimary

Reduced Stent Strategy Versus Conventional Percutaneous Coronary Revascularization in Patients Presenting With STEMI

NCT06227754Not ApplicableRecruitingPrimary

OCT Versus Angiography for Culprit Lesion Revascularization in Acute Myocardial Infarction PatiEnts

NCT04775914Not ApplicableRecruitingPrimary

STEMI Treatment Optimization by Ischemic Postconditioning and IVUS Guidance

NCT05462730Phase 2CompletedPrimary

Pulse Glucocorticoid Therapy in Patients With ST-Segment Elevation Myocardial Infarction

NCT04217304Phase 2TerminatedPrimary

SONOthrombolysis in Patients With an ST-segment Elevation Myocardial Infarction With fibrinoLYSIS (SONOSTEMI-LYSIS) Trial

NCT05848674Not ApplicableCompletedPrimary

CArdiac Brief INtervention: A Feasibility Study to Promote Engagement With Cardiac Rehabilitation

NCT06040528Recruiting

Early Discharge Pathway Registry

NCT06174753Phase 3RecruitingPrimary

Dapagliflozin in STEMI

NCT05785897Not ApplicableRecruitingPrimary

STEMI Treated With a Polymer-free Sirolimus-coated Stent and P2Y12 Inhibitor-based SAPT Versus Conventional DAPT

NCT03858777Not ApplicableRecruiting

Cell Free DNA in Cardiac Sarcoidosis

NCT07195812Phase 4Not Yet RecruitingPrimary

Rivaroxaban for Slow Coronary Flow After PCI in STEMI

NCT06506448RecruitingPrimary

Risk Characterization of Non-culprit Vessels in Patients Undergoing Primary PCI for ST-elevation MI in Multivessel Disease

NCT06465303Phase 2RecruitingPrimary

A Study of RTP-026 to Assess Safety, Tolerability and Efficacy in Patients With ST-Elevation Myocardial Infarction (STEMI)

NCT03822975Not ApplicableCompletedPrimary

Bivalirudin With Prolonged Full Dose Infusion Versus Heparin Alone During Emergency PCI

NCT03611725Not ApplicableCompleted

Comparison of Success Rate Between Distal Radial Approach and Radial Approach in STEMI

Scroll to load more

Research Network

Activity Timeline